Luke Miels, GSK chief commercial officer
GSK readies Blenrep's commercial re-launch in the US, and a push in second line
GSK is gearing up for the revival of multiple myeloma drug Blenrep, having hung onto the salesforce that was assembled when the drug first nabbed …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
